| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 6840 |
| 1 | RANITIDINE HYDROCHLORIDE | 2244 |
| 2 | SITAGLIPTIN | 1670 |
| 3 | PANCRELIPASE | 1297 |
| 4 | EXENATIDE | 1187 |
| 5 | LIRAGLUTIDE | 945 |
| 6 | METFORMIN | 751 |
| 7 | METFORMIN ER 500 MG | 670 |
| 8 | METFORMIN ER 750 MG | 670 |
| 9 | INSULIN GLARGINE | 620 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANITIDINE HYDROCHLORIDE | 2244 | 0.0414 |
| 1 | RANITIDINE | 6840 | 0.0346 |
| 2 | PANCRELIPASE | 1297 | 0.0327 |
| 3 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 588 | 0.0272 |
| 4 | SITAGLIPTIN | 1670 | 0.0230 |
| 5 | EXENATIDE | 1187 | 0.0227 |
| 6 | LIRAGLUTIDE | 945 | 0.0190 |
| 7 | SITAGLIPTIN PHOSPHATE | 29 | 0.0106 |
| 8 | GOLIMUMAB | 116 | 0.0092 |
| 9 | ALOGLIPTIN | 28 | 0.0082 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 2486 |
| 1 | Insulin Analog [EPC] | 1028 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 706 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 538 |
| 4 | Corticosteroid [EPC] | 523 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 440 |
| 6 | Proton Pump Inhibitor [EPC] | 434 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 396 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 385 |
| 9 | Microtubule Inhibitor [EPC] | 379 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 32 | 0.0465 |
| 1 | Photoactivated Radical Generator [EPC] | 3 | 0.0234 |
| 2 | Provitamin D2 Compound [EPC] | 232 | 0.0078 |
| 3 | GLP-1 Receptor Agonist [EPC] | 2486 | 0.0055 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 12 | 0.0053 |
| 5 | Interleukin-17 Receptor A Antagonist [EPC] | 9 | 0.0044 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 9 | 0.0043 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 134 | 0.0041 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 22 | 0.0038 |
| 9 | Amyloid Beta-directed Antibody [EPC] | 13 | 0.0034 |